Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02360267 · ClinicalTrials.gov registry record
Pediatric Bipolar Registry
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 334
- Enrollment target
NCT02360267: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT02360267 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 334 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02360267 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 334 participants
- Enrollment target
Study Summary
The goal of the Pediatric Bipolar Registry (PBR) is to provide a comprehensive assessment regarding the diagnosis and treatment of pediatric bipolar disorder to children and adolescents with any current mood state and/or children/adolescents who are offspring of a parent with bipolar disorder (BD) type I or II and their families.
Primary Outcome
AIM I: The goal of the Pediatric Bipolar Registry (PBR) is to provide a comprehensive assessment regarding the diagnosis of pediatric bipolar disorder to children and adolescents with any current mood state and/or children/adolescents who are offspring of a parent with bipolar disorder (BD) type I or II. Data collected will be utilized to perform a retrospective chart review to include measure outcomes and de-identified demographic information detailed in the attached case report forms. Each of
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2013-08-05 |
| Est. Completion | 2019-02 |
What the finished NCT02360267 record still lists
NCT02360267 is an observational study that tracks outcomes without assigning an intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02360267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02360267 about?
NCT02360267 is a clinical study titled "Pediatric Bipolar Registry". The goal of the Pediatric Bipolar Registry (PBR) is to provide a comprehensive assessment regarding the diagnosis and treatment of pediatric bipolar disorder to children and adolescents with any current mood state and/or children/adolescents who are offspring of a parent with bipolar disorder (BD) t...
What is the current status of trial NCT02360267?
This trial is currently completed. The enrollment target is 334 participants. The study started on 2013-08-05. Estimated completion is 2019-02.
Who is sponsoring clinical trial NCT02360267?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
- NCT05722197 · 334 participants · NA
Assessment of Emotion Regulation Strategies Used When Suicidal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI